Ignite Creation Date:
2024-05-06 @ 11:11 AM
Last Modification Date:
2024-10-26 @ 12:41 PM
Study NCT ID:
NCT03456726
Status:
COMPLETED
Last Update Posted:
2022-12-16
First Post:
2018-03-06
Brief Title:
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkins Lymphoma With EZH2 Gene Mutation
Sponsor:
Eisai Co Ltd
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E7438-J081-206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None